Carmuta 150mg Injection
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Carboplatin (150mg)
Overview Carmuta 150mg Injection
Oncaspar (150mg injection) is indicated for ovarian and small cell lung cancer. Its mechanism involves inhibiting or reducing the proliferation of cancerous cells. Administered intravenously under medical supervision, dosage and frequency are determined individually by your physician based on your condition and may vary. Adhere strictly to the prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue only under your doctor's guidance. Common side effects include nausea, vomiting, tiredness, and elevated liver enzymes. This medication can lower blood cell counts (red and white blood cells), increasing infection and bleeding risks. Report fever, sore throat, chills, unusual bleeding or bruising, and dark urine immediately. Regular blood tests monitoring blood cell counts, heart function, liver health, and uric acid levels are essential. Report any allergic reactions such as rash, itching, or breathing difficulties. Inform your healthcare provider of all other medications you are taking, as interactions are possible. This medicine is contraindicated during pregnancy and breastfeeding; reliable contraception for both partners is crucial throughout treatment.
Uses of Carmuta 150mg Injection
Cancers of the ovary and lung (small cell type)
Major Benefits of Carmuta 150mg Injection:
Administering this medication requires a healthcare professional; please do not attempt self-medication.
Common Side effects of Carmuta 150mg Injection:
- Nausea
- Vomiting
- Anemia (low number of red blood cells)
- Fatigue
- Low blood platelets
- Increased liver enzymes
- Decreased white blood cell count (neutrophils)
- Stomatitis (Inflammation of the mouth)
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
How to use Carmuta 150mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Carmuta 150mg Injection works:
Carmuta 150mg Injection is an antineoplastic agent. Its mechanism of action involves disrupting the cancerous cells' DNA and RNA, thereby inhibiting their proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Carmuta 150mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Carmuta 150mg Injection to pregnant individuals poses a confirmed risk to fetal development and is therefore contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might consider its use if the potential advantages outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Carmuta 150mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
The administration of Carmuta 150mg Injection can potentially reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Exercise caution when administering Carmuta 150mg Injection to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Carmuta 150mg Injection is contraindicated in patients exhibiting severe kidney disease. Routine assessment of kidney function is recommended during treatment.
LiverSAFE IF PRESCRIBED
The use of Carmuta 150mg Injection in patients with hepatic impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary for this population. Physician consultation is recommended.
What if you forget to take Carmuta 150mg Injection :
Omitting a scheduled Carmuta 150mg Injection requires immediate physician consultation.
Facts to Know About Carmuta 150mg Injection
| Label | Value |
|---|---|
| Chemical Type | Platinum Equivalents |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Platinum-based Anticancer Agents |
3,018 People bought this recently